Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Warren

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Frontiers in Pharmacology|October 11, 2024
Deletion of arrestin-3 does not reduce drug-seeking behavior in a longitudinal paradigm of oral morphine self-administrationSarah Warren Gooding, Lindsey Felth, Randi Foxall, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Deletion of arrestin-3 does not improve compulsive drug-seeking behavior in a longitudinal paradigm of oral morphine self-administrationSarah Warren Gooding, Lindsey Felth, Randi Foxall, et al.
Analytical Chemistry|February 17, 2021
High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer CellsLiang Dong, Chung-Ying Huang, Eric J Johnson, et al.
Materials Today. Bio|November 25, 2022
RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patientsLiang Dong, Xinxing Du, Changxue Lu, et al.
Frontiers in Immunology|February 15, 2019
CD56<sup>dim</sup> CD16<sup>-</sup> Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-αLazar Vujanovic, Christopher Chuckran, Yan Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic MelanomaIsabelle Girault, Julien Adam, Shensi Shen, et al.
Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
NPJ Precision Oncology|December 15, 2022
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockadeIoannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, et al.
Journal of Virology|April 20, 2007
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivoZilin Nie, Gary D Bren, Stacey R Vlahakis, et al.
British Journal of Cancer|January 19, 2021
Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of EnglandSarah E R Bailey, Gary A Abel, Alex Atkins, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|October 11, 2024
Deletion of arrestin-3 does not reduce drug-seeking behavior in a longitudinal paradigm of oral morphine self-administrationSarah Warren Gooding, Lindsey Felth, Randi Foxall, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Deletion of arrestin-3 does not improve compulsive drug-seeking behavior in a longitudinal paradigm of oral morphine self-administrationSarah Warren Gooding, Lindsey Felth, Randi Foxall, et al.
Analytical Chemistry|February 17, 2021
High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer CellsLiang Dong, Chung-Ying Huang, Eric J Johnson, et al.
Materials Today. Bio|November 25, 2022
RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patientsLiang Dong, Xinxing Du, Changxue Lu, et al.
Frontiers in Immunology|February 15, 2019
CD56<sup>dim</sup> CD16<sup>-</sup> Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-αLazar Vujanovic, Christopher Chuckran, Yan Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic MelanomaIsabelle Girault, Julien Adam, Shensi Shen, et al.
Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.
NPJ Precision Oncology|December 15, 2022
Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockadeIoannis A Vathiotis, Leonidas Salichos, Sandra Martinez-Morilla, et al.
Journal of Virology|April 20, 2007
Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivoZilin Nie, Gary D Bren, Stacey R Vlahakis, et al.
British Journal of Cancer|January 19, 2021
Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of EnglandSarah E R Bailey, Gary A Abel, Alex Atkins, et al.
Pageof 9